Skip to content

The Impact of RPh201 on CVS Patients: Clinical and fMRI Measurements

Status
Withdrawn
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01417299
Acronym
CVS
Enrollment
0
Registered
2011-08-16
Start date
2011-10-31
Completion date
2018-10-31
Last updated
2015-09-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Vegetative State

Keywords

chronic vegetative state, RPh201, functional MRI

Brief summary

The investigators are studying the impact of RPh201 on chronic vegetative patients. RPh201 has been reported to induce neuronal regeneration in animal models. Evaluation will be done by combining clinical /behavioral assessment with fMRI studies.

Interventions

DIETARY_SUPPLEMENTRPh201

Patients will receive 400 microliter s.c., of RPh201 twice a week for 3 months

DIETARY_SUPPLEMENTsaline

Patients will receive 400 microliter s.c., of saline twice a week for 3 months

Sponsors

Hadassah Medical Organization
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Chronic vegetative patients

Exclusion criteria

* Inability to go through an MRI scans (i.e. metal implants, neurotransmitters)and pregnancy

Design outcomes

Primary

MeasureTime frameDescription
change in the awareness status of the patients.3-6 monthsClinical and laboratory assessment will be done every two weeks along the treatment period fMRI assessment will be performed 3 times: before the treatment, immediate afterwards and one month following treatment cessation.

Secondary

MeasureTime frameDescription
change in the awareness status of the patients.1 month following the end of the trialclinical and fMRI assessment will be performed 1 month following treatment cessation

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026